Table 2.
Open in new tab

Breakdown of samples belonging to each group [by dominant urease producers] for each disease type.

Bacilli and Proteobacteria- dominatedBacteroidales and Clostridiales- dominatedOtheraNo urease producersProbiotic dominated
CD20 [6.87%]238 [81.79%]520 [6.87%]8 [2.75%]
UC13 [6.07%]186 [86.92%]47 [3.27%]4 [1.87%]
Non-IBD controls055 [100%]000
Bacilli and Proteobacteria- dominatedBacteroidales and Clostridiales- dominatedOtheraNo urease producersProbiotic dominated
CD20 [6.87%]238 [81.79%]520 [6.87%]8 [2.75%]
UC13 [6.07%]186 [86.92%]47 [3.27%]4 [1.87%]
Non-IBD controls055 [100%]000

IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis.

aOne patient with CD and one patient with UC had Collinsella as a main urease producer, the other ones had no dominant urease-producing group

Table 2.
Open in new tab

Breakdown of samples belonging to each group [by dominant urease producers] for each disease type.

Bacilli and Proteobacteria- dominatedBacteroidales and Clostridiales- dominatedOtheraNo urease producersProbiotic dominated
CD20 [6.87%]238 [81.79%]520 [6.87%]8 [2.75%]
UC13 [6.07%]186 [86.92%]47 [3.27%]4 [1.87%]
Non-IBD controls055 [100%]000
Bacilli and Proteobacteria- dominatedBacteroidales and Clostridiales- dominatedOtheraNo urease producersProbiotic dominated
CD20 [6.87%]238 [81.79%]520 [6.87%]8 [2.75%]
UC13 [6.07%]186 [86.92%]47 [3.27%]4 [1.87%]
Non-IBD controls055 [100%]000

IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis.

aOne patient with CD and one patient with UC had Collinsella as a main urease producer, the other ones had no dominant urease-producing group

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close